Scott D. Kahn, Ph.D.
Board Member
Exagen Inc. (XGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott D. Kahn, Ph.D.
Scott D. Kahn, Ph.D. is recorded as Board Member at Exagen Inc. (XGN). Exagen Inc. reported in an 8-K filed April 26, 2024 that Scott D. Kahn, Ph.D. was appointed Class I director, effective June 10, 2024.
“the Board appointed, effective as of June 10, 2024 (the "Effective Time"), Scott D. Kahn, Ph.D. to serve as a Class I director, with an initial term expiring at the Company's 2026 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Exagen Inc.
Other people whose current roles at this company are on record from its filings.
- John Aballi CEO, CFO, Board Member
- Tina S. Nova Chairman
- Jeffrey Black CFO
- Mark Hazeltine COO
- Bruce C. Robertson Board Member
- Charles S. McKhann Board Member
- Frank Stokes Board Member
- Paul Kim Board Member
- Scott D. Kahn Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.